| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Kinsmen Laboratory of Neurological Research, University of British Columbia, Vancouver, British Columbia, Canada
We used reverse transcriptase-polymerase chain reaction and Western blotting techniques to measure the levels of complement mRNAs and their protein products in Alzheimer's disease (AD) brain compared with non-AD brain. mRNAs for C1q, C1r, C1s, C2, C3, C4, C5, C6, C7, C8, and C9 were detected in the 11 regions of brain that were investigated. The mRNA levels were markedly up-regulated in affected areas of AD brain. In the entorhinal cortex, hippocampus, and midtemporal gyrus, which had dense accumulations of plaques and tangles, C1q mRNA was increased 11- to 80-fold over control levels, and C9 mRNA 10- to 27-fold. These levels were substantially higher than in the livers of the same cases. Western blot analysis of AD hippocampus established the presence of all of the native complement proteins as well as their activation products C4d, C3d, and the membrane attack complex. These data indicate that high levels of complement are being produced in affected areas of AD brain, that full activation of the classical complement pathway is continuously taking place, and that this activation may be contributing significantly to AD pathology.
This article has been cited by other articles:
![]() |
M. Maier, Y. Peng, L. Jiang, T. J. Seabrook, M. C. Carroll, and C. A. Lemere Complement C3 Deficiency Leads to Accelerated Amyloid {beta} Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice J. Neurosci., June 18, 2008; 28(25): 6333 - 6341. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Woodruff, J. W. Crane, L. M. Proctor, K. M. Buller, A. B. Shek, K. de Vos, S. Pollitt, H. M. Williams, I. A. Shiels, P. N. Monk, et al. Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration FASEB J, July 1, 2006; 20(9): 1407 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Kraus, G. S. Elliott, H. Chute, T. Horan, K. H. Pfenninger, S. D. Sanford, S. Foster, S. Scully, A. A. Welcher, and V. M. Holers CSMD1 Is a Novel Multiple Domain Complement-Regulatory Protein Highly Expressed in the Central Nervous System and Epithelial Tissues J. Immunol., April 1, 2006; 176(7): 4419 - 4430. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Benard, B. J. Gonzalez, M.-T. Schouft, A. Falluel-Morel, D. Vaudry, P. Chan, H. Vaudry, and M. Fontaine Characterization of C3a and C5a Receptors in Rat Cerebellar Granule Neurons during Maturation: NEUROPROTECTIVE EFFECT OF C5a AGAINST APOPTOTIC CELL DEATH J. Biol. Chem., October 15, 2004; 279(42): 43487 - 43496. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-Q. Xiong, W. Qian, K. Suzuki, and J. O. McNamara Formation of Complement Membrane Attack Complex in Mammalian Cerebral Cortex Evokes Seizures and Neurodegeneration J. Neurosci., February 1, 2003; 23(3): 955 - 960. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McGeer and E. G. McGeer Innate Immunity, Local Inflammation, and Degenerative Disease Sci. Aging Knowl. Environ., July 24, 2002; 2002(29): re3 - 3. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Speth, T. Schabetsberger, I. Mohsenipour, G. Stockl, R. Wurzner, H. Stoiber, C. Lass-Florl, and M. P. Dierich Mechanism of Human Immunodeficiency Virus-Induced Complement Expression in Astrocytes and Neurons J. Virol., March 7, 2002; 76(7): 3179 - 3188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, W. W. Tourtellotte, E. G. McGeer, and P. L. McGeer Marked increase in cyclooxygenase-2 in ALS spinal cord: Implications for therapy Neurology, September 25, 2001; 57(6): 952 - 956. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Complement Components, but Not Complement Inhibitors, Are Upregulated in Atherosclerotic Plaques Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1214 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Larsen, R. R. Regal, and J. F. Regal Trimellitic Anhydride-Induced Allergic Response in the Guinea Pig Lung Involves Antibody-Dependent and -Independent Complement System Activation J. Pharmacol. Exp. Ther., April 13, 2001; 296(2): 284 - 292. [Abstract] [Full Text] |
||||
![]() |
E. G. McGeer and P. L. McGeer Innate Immunity in Alzheimer's Disease: A Model for Local Inflammatory Reactions Mol. Interv., April 1, 2001; 1(1): 22 - 29. [Abstract] [Full Text] |
||||
![]() |
C. Speth, G. Stöckl, I. Mohsenipour, R. Würzner, H. Stoiber, C. Lass-Flörl, and M. P. Dierich Human Immunodeficiency Virus Type 1 Induces Expression of Complement Factors in Human Astrocytes J. Virol., March 15, 2001; 75(6): 2604 - 2615. [Abstract] [Full Text] |
||||
![]() |
S. A. O'Barr, J. Caguioa, D. Gruol, G. Perkins, J. A. Ember, T. Hugli, and N. R. Cooper Neuronal Expression of a Functional Receptor for the C5a Complement Activation Fragment J. Immunol., March 15, 2001; 166(6): 4154 - 4162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yasojima, C. Schwab, E. G. McGeer, and P. L. McGeer Generation of C-Reactive Protein and Complement Components in Atherosclerotic Plaques Am. J. Pathol., March 1, 2001; 158(3): 1039 - 1051. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. McGeer and E. G. McGeer Autotoxicity and Alzheimer Disease Arch Neurol, June 1, 2000; 57(6): 789 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K.-H. Schafer, W. J. Schwaeble, C. Post, P. Salvati, M. Calabresi, R. B. Sim, F. Petry, M. Loos, and E. Weihe Complement C1q Is Dramatically Up-Regulated in Brain Microglia in Response to Transient Global Cerebral Ischemia ,2 J. Immunol., May 15, 2000; 164(10): 5446 - 5452. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Stoltzner, T. J. Grenfell, C. Mori, K. E. Wisniewski, T. M. Wisniewski, D. J. Selkoe, and C. A. Lemere Temporal Accrual of Complement Proteins in Amyloid Plaques in Down’s Syndrome with Alzheimer’s Disease Am. J. Pathol., February 1, 2000; 156(2): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Tanhehco, K. Yasojima, P. L. McGeer, and B. R. Lucchesi Acute Cocaine Exposure Up-Regulates Complement Expression in Rabbit Heart J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 201 - 208. [Abstract] [Full Text] |
||||
![]() |
S. D. Yan, A. Roher, A. M. Schmidt, and D. M. Stern Cellular Cofactors for Amyloid {beta}-Peptide-Induced Cell Stress : Moving from Cell Culture to in Vivo Am. J. Pathol., November 1, 1999; 155(5): 1403 - 1411. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |